What causes cell death in Parkinson's disease?
Year: 2009
Type: review
Abstract: Currently, there is no proven neuroprotective or neurorestorative therapy for Parkinson's disease (PD). Several advances in the genetics of PD have created an opportunity to develop mechanistic-based therapies that hold particular promise for identifying agents that slow and even halt the progression of PD, as well as restore function. Here we review many of the advances in the last decade regarding the identification of new targets for the treatment of PD based on understanding the molecular mechanisms of how mutations in genes linked to PD cause neurodegeneration.
Source: Annals of Neurology
DOI: 10.1002/ana.21573
Authors: Amitabh Gupta, Valina L. Dawson, Ted M. Dawson
Institutions: Johns Hopkins University, Johns Hopkins Medicine
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2028800707
